Family Medicine Doctors in Shiner, TX Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Ralph A Wagner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 124 E Wolters 2nd, Shiner, TX 77984 Phone: 361-594-3824 Fax: 361-594-4104 |
 Joy Sharon Bowen, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 714 N Ave E, Shiner, TX 77984 Phone: 361-594-2925 Fax: 361-594-4253 |
Marshall C Bishop, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 124 E Wolters 2nd, Shiner, TX 77984 Phone: 361-594-3824 Fax: 361-594-4104 |
Timothy J Wagner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 124 E Wolters 2nd, Shiner, TX 77984 Phone: 361-594-3824 Fax: 361-594-4104 |
News Archive
Researchers to discuss gene that may be linked to polycystic ovary syndrome
Researchers in endocrinology and obstetrics and gynecology at Cedars-Sinai Medical Center will make several presentations at the upcoming annual meetings of two medical organizations , the Androgen Excess Society (June 1, 2007) and the Endocrine Society (June 2-5, 2007).
New breast biopsy technique
Researchers have developed a new breast biopsy technique that could lead to decreased procedure times and reduced patient discomfort and morbidity, according to a study performed at Roberts Research Institute, the University of Western Ontario and London Health Sciences Centre, London, ON, Canada.
Autologous hematopoietic cell transplant may induce sustained remission of multiple sclerosis
New clinical trial results provide evidence that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system.
FG-2216 drug offers new treatment option for kidney disease-related anemia
A new drug called FG-2216 can stimulate production of the hormone erythropoietin (EPO) in dialysis patients—possibly offering a new approach to treatment of kidney disease-related anemia, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
› Verified 2 days ago